Table 2
Invasive Cancer Incidence by Primary Site and Age at Diagnosis
Michigan Residents, 2016

Primary Site
  (ICD-O-3 Cancer Incidence
Site Groupings)
 
Total Less than 50 Years 50 - 74 Years 75 Years & Over
Number Age-
Adjusted
Rate
Number Age-
Specific
Rate
Number Age-
Specific
Rate
Number Age-
Specific
Rate
Gastrointestinal Tract
& Digestive System
10,818 86.7 ±1.6 1,016 16.3 ±1.0 6,699 220.4 ±5.1 3,103 461.8 ±15.3
Lip, Oral Cavity & Pharynx 1,476 11.8 ±0.6 194 3.1 ±0.4 1,032 34.0 ±2.1 250 37.2 ±4.6
Stomach 682 5.6 ±0.4 61 1.0 ±0.2 399 13.1 ±1.3 222 33.0 ±4.3
Colon 3,157 26.0 ±0.9 334 5.4 ±0.6 1,683 55.4 ±2.6 1,140 169.7 ±9.6
Rectum 1,548 12.6 ±0.6 218 3.5 ±0.5 1,025 33.7 ±2.1 305 45.4 ±5.1
Pancreas 1,641 13.0 ±0.6 82 1.3 ±0.3 997 32.8 ±2.0 562 83.6 ±6.8
Other Gastrointestinal
Tract & Digestive System
2,314 17.9 ±0.7 127 2.0 ±0.4 1,563 51.4 ±2.5 624 92.9 ±7.2
Respiratory System &
Pleura
8,295 64.8 ±1.4 272 4.4 ±0.5 5,500 181.0 ±4.7 2,523 375.5 ±14.0
Larynx 441 3.3 ±0.3 28 0.4 ±0.2 341 11.2 ±1.2 72 10.7 ±2.5
Lung & Bronchus 7,751 60.6 ±1.3 230 3.7 ±0.5 5,092 167.6 ±4.5 2,429 361.5 ±13.7
Other Respiratory 103 0.9 ±0.2 14 0.2 ±0.1 67 2.2 ±0.5 22 3.3 ±1.4
Bones & Soft Tissue 440 4.0 ±0.4 139 2.2 ±0.4 201 6.6 ±0.9 100 14.9 ±2.9
Melanoma of Skin 2,426 20.5 ±0.8 469 7.5 ±0.7 1,405 46.2 ±2.4 552 82.1 ±6.8
Breast 7,925 66.1 ±1.5 1,339 21.5 ±1.1 4,980 163.9 ±4.5 1,606 239.0 ±11.3
Genitourinary Organs 15,286 119.6 ±1.9 1,285 20.7 ±1.1 10,573 347.9 ±6.3 3,428 510.1 ±16.0
Cervix Uteri 335 3.4 ±0.4 163 2.6 ±0.4 141 4.6 ±0.8 31 4.6 ±1.6
Corpus Uteri 1,937 15.0 ±0.7 197 3.2 ±0.4 1,459 48.0 ±2.4 281 41.8 ±4.9
Ovary 660 5.5 ±0.4 128 2.1 ±0.4 405 13.3 ±1.3 127 18.9 ±3.3
Prostate Gland 6,727 49.5 ±1.2 124 2.0 ±0.4 5,392 177.4 ±4.6 1,211 180.2 ±9.9
Other Genital 722 6.6 ±0.5 269 4.3 ±0.5 315 10.4 ±1.1 138 20.5 ±3.4
Urinary Bladder 2,765 22.2 ±0.8 109 1.8 ±0.3 1,481 48.7 ±2.5 1,175 174.9 ±9.8
Kidney and Renal Pelvis 2,020 16.5 ±0.7 290 4.7 ±0.5 1,316 43.3 ±2.3 414 61.6 ±5.9
Other Urinary 120 0.9 ±0.2 5 *   64 2.1 ±0.5 51 7.6 ±2.1
Brain & Other Central
Nervous System
720 6.4 ±0.5 244 3.9 ±0.5 349 11.5 ±1.2 127 18.9 ±3.3
Lymphomas 2,585 21.9 ±0.8 483 7.8 ±0.7 1,377 45.3 ±2.4 725 107.9 ±7.7
Hodgkin Lymphoma 271 2.7 ±0.3 167 2.7 ±0.4 78 2.6 ±0.6 26 3.9 ±1.5
Non-Hodgkin Lymphoma 2,314 19.2 ±0.8 316 5.1 ±0.6 1,299 42.7 ±2.3 699 104.0 ±7.6
Multiple Myeloma 862 6.9 ±0.5 52 0.8 ±0.2 523 17.2 ±1.5 287 42.7 ±4.9
Leukemias 1,556 13.2 ±0.7 281 4.5 ±0.5 813 26.8 ±1.8 462 68.8 ±6.2
All Other 3,596 31.6 ±1.0 871 14.0 ±0.9 1,727 56.8 ±2.7 998 148.5 ±9.0
Total 54,509 441.6 ±3.6 6,451 103.7 ±2.5 34,147 1123.7 ±10.3 13,911 2070.2 ±26.4
               

Notes: Age-Specific Rates are per 100,000 population in a specific age group. Age-Adjusted Rates are per 100,000 population. Age-adjusted rates are computed by the direct method, using as the standard population the age distribution of the total population of the United States for the year 2000. Adding and subtracting the number shown after the ± symbol from the rate creates a confidence interval indicating that the true rate lies between the lower and upper bounds of this interval with 95 % statistical confidence.
Case : A case is defined as a person with any newly diagnosed cancer with a behavior code of 3 (malignant primary site). Both in-situ and invasive urinary bladder cancer cases are included, in order to be consistent with SEER tabulations from the National Cancer Institute.
* : A rate is not calculated when there are fewer than 20 total events, or fewer than 6 events in an age category, because the width of the confidence interval would negate any usefulness for comparative purposes.
Source: Michigan Resident Cancer Incidence File. Updated with cases processed through November 30, 2018. Division for Vital Records & Health Statistics, Michigan Department of Health & Human Services.
Last Updated: July 23, 2019